Kazuya Kabayama
Suita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Electrostatic Interaction Analysis Between GM3 and Insulin Receptor.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 19, 2026
An integrative multi-omics landscape of multi-dimensional cellular stress and metabolic reprogramming in melanoma treated with targeted alpha therapy.
Journal: Journal of nanobiotechnology
Published: March 27, 2026
A new eudesmane type sesquiterpenoid from the stem bark of Aglaia pachyphylla with cytotoxic and anti-inflammatory activities.
Journal: Natural product research
Published: February 08, 2026
CT-Based Attenuation Correction Algorithm for Quantitative L-Shell X-Ray Fluorescence Imaging of Gold Nanoparticles in Murine Tumor Tissues.
Journal: Diseases (Basel, Switzerland)
Published: October 23, 2025
Programmable Antigen-Specific Immunity via Self-Adjuvanting Nanovaccines Co-Delivering Immune Modulators.
Journal: Angewandte Chemie (International ed. in English)
Published: September 17, 2025
Pachyphylinin A-B: two novel seco-apotirucallane triterpenoids with cytotoxic activities from the stem bark of Aglaia pachyphylla.
Journal: Journal of natural medicines
Published: March 20, 2025
Preclinical evaluation of [211At]At-AuNP-ABDMPL16 for targeted alpha therapy in Melanoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 21, 2025
Modulation function of sphingomyelin molecular species in TLR4 signaling and cell death.
Journal: Cell reports
Published: November 28, 2024
Single-cell mass spectrometry imaging of lipids in HeLa cells via tapping-mode scanning probe electrospray ionization.
Journal: Communications chemistry
Published: November 19, 2024
Development of a FUT8 Inhibitor with Cellular Inhibitory Properties.
Journal: Angewandte Chemie (International ed. in English)
Published: August 02, 2024
Synthesis and immunological evaluation of TLR1/2 ligand-conjugated RBDs as self-adjuvanting vaccine candidates against SARS-CoV-2.
Journal: Chemical communications (Cambridge, England)
Published: March 18, 2024
Immunomodulatory of sesquiterpenoids and sesquiterpenoid dimers-based toll-like receptor 4 (TLR4) from Dysoxylum parasiticum stem bark.
Journal: Scientific reports
Published: February 16, 2024
Last Updated: 09/26/2026